Director/PDMR Shareholding

RNS Number : 1492F

GlaxoSmithKline PLC

16 February 2018

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mrs V A Whyte
b)	Position/status	Company Secretary
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	A conditional award of Ordinary Shares under the Company's 2017 Performance Share Plan. Vesting of the award is subject to meeting performance criteria over a three-year period.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£12.908	11,800
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2018-02-14
f)	Place of the transaction	n/a

 

END

 

 

DSHFQLFFVLFFBBV